THU338 Risks Of Stroke, Its Subtypes And Atrial Fibrillation Associated With Glucagon-like Peptide 1 Receptor Agonists Versus Sodium-glucose Cotransporter 2 Inhibitors: A Real-world Population-based Study In Hong Kong

Disclosure: D. Lui: None. E. Tang: None. T. Wu: None. I. Au: None. C. Lee: None. Y. Woo: None. K.C. Tan: None. C. Wong: None. Objectives: There are limited data on head-to-head comparative risk of stroke between sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lui, David, Tang, Eric, Wu, Tingting, Au, Ivan, Ho Lee, Chi, Cho Woo, Yu, CB Tan, Kathryn, Wong, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555345/
http://dx.doi.org/10.1210/jendso/bvad114.771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555345/
http://dx.doi.org/10.1210/jendso/bvad114.771

Ejemplares similares